ALBERTI VIOLETTI, SILVIA
ALBERTI VIOLETTI, SILVIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma
2024 F. Bagnoli, G. Pini, B. Ziccheddu, A. Bonometti, S. Alberti-Violetti, L. Venegoni, G. Isimbaldi, M.C. Da Vià, A. Ferrari, L. Baldini, A. Neri, F. Onida, N. Bolli, E. Berti
The unexpected guest: Cytotoxic, pseudolymphoma-like reaction at the site of primary cutaneous follicle centre B-cell lymphoma in a patient receiving secukinumab for psoriasis
2024 C. Pescia, G. Pini, S. Tabano, E. Berti, S. Alberti Violetti, G.A. Croci
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review
2024 G. Avallone, G. Roccuzzo, A. Pileri, C. Agostinelli, C.A. Maronese, C. Aquino, G. Tavoletti, F. Onida, P. Fava, S. Ribero, A.V. Marzano, E. Berti, P. Quaglino, S. Alberti‐violetti
T follicular helper phenotype mycosis fungoides associated with acanthosis nigricans
2023 C.B. Spigariolo, E. Berti, A. Cerri, L. Venegoni, G. Croci, S.A. Violetti
Disseminated superficial actinic porokeratosis following hydroxyurea treatment: A case report
2023 M. Romagnuolo, D. Riva, S. Alberti Violetti, A. Di Benedetto, F. Barberi, C. Moltrasio
Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study
2023 G. Avallone, C.A. Maronese, G. Murgia, C.G. Carrera, L. Mastorino, G. Roccuzzo, P. Dapavo, S. Alberti-Violetti, P. Quaglino, S. Ribero, A.V. Marzano
Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor palbociclib
2023 M. Romagnuolo, S. Alberti Violetti, D. Riva, F. Barberi, C. Moltrasio
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals
2022 G. Avallone, C.A. Maronese, C. Conforti, P. Fava, L. Gargiulo, A.V. Marzano, C. Massone, L. Mastorino, A. Paradisi, A. Pileri, P. Quaglino, N. Rizzo, S. Ribero, G. Roccuzzo, G. Tavoletti, C.A. Vignoli, I. Zalaudek, E. Berti, S. Alberti-Violetti
Maculopapular rash: An overlooked monkeypox diagnostic clue?
2022 G. Avallone, C.A. Maronese, E. Quattri, G. Roccuzzo, L. Mastorino, S. Alberti-Violetti, S. Ramoni, A. Lucchini, S. Delmonte, P. Quaglino, A.V. Marzano, S. Ribero
Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management
2022 P. Fava, G. Roccuzzo, S. Alberti-Violetti, V. Grandi, A. Pileri, N. Pimpinelli, E. Berti, P. Quaglino
Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors
2022 C.B. Spigariolo, F. Barei, C.A. Maronese, F. Barberi, A. Cattaneo, S.A. Violetti
MYCOSIS FUNGOIDES AND SEZARY SYNDROME THE JANUS BIFRONS OF THE CUTANEOUS T-CELL LYMPHOMAS: EVALUATION OF SPECIFIC PHENOTYPE AND GENETIC ALTERATIONS.
2021 S. ALBERTI VIOLETTI
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part II
2021 E. Schmidt, H. Rashid, A.V. Marzano, A. Lamberts, G. Di Zenzo, G.F.H. Diercks, S. Alberti‐Violetti, R.J. Barry, L. Borradori, M. Caproni, B. Carey, M. Carrozzo, G. Cianchini, A. Corrà, F.G. Dikkers, C. Feliciani, G. Geerling, G. Genovese, M. Hertl, P. Joly, J.M. Meijer, V. Mercadante, D.F. Murrell, M. Ormond, H.H. Pas, A. Patsatsi, S. Rauz, B.D. Rhijn, M. Roth, J. Setterfield, D. Zillikens, N. C. Prost, G. Zambruno, B. Horváth, F. Caux
An expert consensus report on mycosis fungoides in Italy: Epidemiological impact and diagnostic-therapeutic pathway
2021 S. Alberti Violetti, M. Alaibac, M. Ardigò, A. Baldo, N. Di Meo, C. Massone, F. Onida, G. Simontacchi, I. Zalaudek, N. Pimpinelli, P. Quaglino, E. Berti
Primary cutaneous gamma-delta T cell lymphomas: a case series and overview of the literature
2021 S. Alberti Violetti, C. Maronese, L. Venegoni, V. Merlo, E. Berti
The microenvironment’s role in mycosis fungoides and sézary syndrome : From progression to therapeutic implications
2021 A. Pileri, A. Guglielmo, V. Grandi, S.A. Violetti, D. Fanoni, P. Fava, C. Agostinelli, E. Berti, P. Quaglino, N. Pimpinelli
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of Mycosis Fungoides: results of an E-Delphi consensus
2021 V. Grandi, A. Baldo, E. Berti, P. Quaglino, S. Rupoli, M. Alaibac, S. Alberti-Violetti, P. Amerio, V. Brazzelli, P.L. Bruni, P. Calzavara-Pinton, A. Parodi, E. Cozzani, M. Burlando, M. Fargnoli, D. Gambini, P. Iacovelli, A. Pacifico, C. Longo, G. Monfrecola, A. Motolese, G. Mozzicafreddo, C. Cota, P. Pigatto, A. Pileri, P. Savoia, M. Simonacci, M. Venturini, A. Offidani, E. Molinelli, M. Pellegrino, E. Trovato, R. Piccinno, K. Lawrence, N. Pimpinelli
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
2021 P. Quaglino, P. Fava, A. Pileri, V. Grandi, M. Sanlorenzo, V. Panasiti, A. Guglielmo, S. Alberti-Violetti, M. Novelli, C. Astrua, M. Rubatto, L. Tonella, E. Berti, N. Pimpinelli, S. Osella Abate, M.T. Fierro, M. Vermeer, J.J. Scarisbrick, S. Ribero
CCR4 in cutaneous T-cell lymphoma: therapeutic targeting of a pathogenic driver
2021 J.P. Nicolay, J.D. Albrecht, S. Alberti-Violetti, E. Berti
European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I
2021 H. Rashid, A. Lamberts, L. Borradori, S. Alberti-Violetti, R.J. Barry, M. Caproni, B. Carey, M. Carrozzo, F. Caux, G. Cianchini, A. Corra, G.F.H. Diercks, F.G. Dikkers, G. Di Zenzo, C. Feliciani, G. Geerling, G. Genovese, M. Hertl, P. Joly, A.V. Marzano, J.M. Meijer, V. Mercadante, D.F. Murrell, M. Ormond, H.H. Pas, A. Patsatsi, C. Prost, S. Rauz, B.D. van Rhijn, M. Roth, E. Schmidt, J. Setterfield, G. Zambruno, D. Zillikens, B. Horvath